We are live on ! Find out more
DBTX

Decibel Therapeutics, Inc. Common Stock
DBTX

Delisted

DBTX was delisted on the 22nd of September, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of DBTX yet.

DBTX Hedge Fund Activity: Q1 2024 in Review

0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Decibel Therapeutics, Inc. Common Stock (DBTX) for Q1 2024, worth a combined $0 — down 100% from $36.4K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DBTX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Atlas Capital Advisors, exiting entirely with an estimated $36.4K sold.

  • 0 institutional investors held Decibel Therapeutics, Inc. Common Stock (DBTX) as of Q1 2024, down from 1 in Q4 2023.
  • Funds reported $0 of Decibel Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Decibel Therapeutics, Inc. Common Stock positions in Q1 2024 and 1 closed out, a net change of -1 holder.
  • The largest Decibel Therapeutics, Inc. Common Stock seller in Q1 2024 was Atlas Capital Advisors, an estimated $36.4K sold.

Based on aggregated 13F filings for Q1 2024.